RIGL

$1.10
-$0.06 (-5.2%)
Closing price September 23, 2022
Thursday's top analyst upgrades and downgrades included Affirm, Bloom Energy, Carlyle, Dutch Bros, Fiserv, Hanesbrands, LyondellBasell Industries, Microsoft, Rigel Pharmaceutical, Target, Tesla and...
Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) has announced that it will push forward with a midstage trial in the treatment of COVID-19.
Thursday's top analyst upgrades and downgrades included Costco, Enphase Energy, Etsy, Moderna, Novavax, Regeneron Pharmaceuticals, Roku, Square, Teva Pharmaceutical, Wayfair and Zynga.